Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Gross Margin
Rohto Pharmaceutical Co Ltd

57.4%
Current
58%
Average
31.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.4%
=
Gross Profit
161.8B
/
Revenue
282.1B

Gross Margin Across Competitors

Country JP
Market Cap 640.7B JPY
Gross Margin
57%
Country FR
Market Cap 176B EUR
Gross Margin
74%
Country UK
Market Cap 117.3B GBP
Gross Margin
0%
Country IN
Market Cap 5.7T INR
Gross Margin
52%
Country UK
Market Cap 34.7B GBP
Gross Margin
62%
Country DE
Market Cap 27.7B EUR
Gross Margin
58%
Country US
Market Cap 25.1B USD
Gross Margin
72%
Country JP
Market Cap 2.9T JPY
Gross Margin
38%
Country IN
Market Cap 1.2T INR
Gross Margin
56%
Country IN
Market Cap 909.1B INR
Gross Margin
49%
Country US
Market Cap 10.2B USD
Gross Margin
35%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
640.7B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.4%
=
Gross Profit
161.8B
/
Revenue
282.1B
What is the Gross Margin of Rohto Pharmaceutical Co Ltd?

Based on Rohto Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 57.4%.